Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 43, Pages E2939-E2948
Publisher
Proceedings of the National Academy of Sciences
Online
2012-09-29
DOI
10.1073/pnas.1206400109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
- (2012) K. Meirelles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells
- (2011) Séverine Cruet-Hennequart et al. CELL CYCLE
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine
- (2011) Glenda Nicioli da Silva et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth
- (2011) Jianpeng Wang et al. MOLECULAR BIOLOGY REPORTS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
- (2011) Ursula A. Matulonis et al. PLoS One
- Clinical significance of side population in ovarian cancer cells
- (2011) Shinji Hosonuma et al. Human Cell
- Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
- (2010) Joon Tae Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
- (2010) X. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Cancer stem cells: a model in the making
- (2009) Lauren L Campbell Marotta et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN- Antitumor Effects
- (2008) L. Moserle et al. CANCER RESEARCH
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
- (2008) J.-H. Choi et al. CANCER RESEARCH
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started